Refractory AML: Clinical Trials

1 trial for Refractory AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Refractory AML: new trials by email Literature Review of Refractory AML trials Research Report on Refractory AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia
NEI-01 - Advanced Solid Tumor, Relapsed AML
Phase 1UnknownNew Epsilon Innovation Limited242022-04-252023-07-27

Narrower conditions

Leukemia, Myeloid, Acute (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

New Epsilon Innovation Limited (1)

Countries

Hong Kong (1)

Top investigators

Christine Kwok, PhD (1)